Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joshua Smith

Showing results (271-280 of 315) with videos related to

Pageof 32
Sort By:
Cell Reports Methods|January 2, 2023
An immunocompetent rectal cancer model to study radiation therapyJin K Kim, Chao Wu, Michael Del Latto, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 1, 2018
Cellular localization of PD-L1 expression in mismatch-repair-deficient and proficient colorectal carcinomasSandy Liu, Mithat Gӧnen, Zsofia K Stadler, et al.
Annals of Surgery|April 22, 2024
Association of Lateral Pelvic Lymph Nodes with Disease Recurrence and Organ Preservation in Patients with Distal Rectal Adenocarcinoma Treated with Total Neoadjuvant TherapyNathalie R A Beets, Floris S Verheij, Hannah Williams, et al.
Journal of Clinical Medicine|April 27, 2024
Oncologic Outcomes of Salvage Abdominoperineal Resection for Anal Squamous Cell Carcinoma Initially Managed with ChemoradiationRoni Rosen, Felipe F Quezada-Diaz, Mithat Gönen, et al.
Molecular Oncology|April 5, 2021
KRAS mutant rectal cancer cells interact with surrounding fibroblasts to deplete the extracellular matrixJin K Kim, Michael R Marco, Seo-Hyun Choi, et al.
Journal of Surgical Education|August 27, 2020
Does Intentional Support of Degree Programs in General Surgery Residency Affect Research Productivity or Pursuit of Academic Surgery? A Multi-Institutional StudyChelsea A Isom, Erika Kristen Bisgaard, Kendrick M Campbell, et al.
NPJ Precision Oncology|May 31, 2024
Mediator kinase inhibition impedes transcriptional plasticity and prevents resistance to ERK/MAPK-targeted therapy in KRAS-mutant cancersDaniel P Nussbaum, Colin A Martz, Andrew M Waters, et al.
Pharmacoepidemiology and Drug Safety|October 10, 2024
The FDA Sentinel Real World Evidence Data Enterprise (RWE-DE)Rishi J Desai, Keith Marsolo, Joshua Smith, et al.
JAMA Oncology|March 23, 2018
Adoption of Total Neoadjuvant Therapy for Locally Advanced Rectal CancerAndrea Cercek, Campbell S D Roxburgh, Paul Strombom, et al.
JCI Insight|August 18, 2017
MTG16 is a tumor suppressor in colitis-associated carcinomaElizabeth M McDonough, Caitlyn W Barrett, Bobak Parang, et al.
Pageof 32

Showing results (271-280 of 315) with videos related to

Sort By:
Pageof 32
Cell Reports Methods|January 2, 2023
An immunocompetent rectal cancer model to study radiation therapyJin K Kim, Chao Wu, Michael Del Latto, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 1, 2018
Cellular localization of PD-L1 expression in mismatch-repair-deficient and proficient colorectal carcinomasSandy Liu, Mithat Gӧnen, Zsofia K Stadler, et al.
Annals of Surgery|April 22, 2024
Association of Lateral Pelvic Lymph Nodes with Disease Recurrence and Organ Preservation in Patients with Distal Rectal Adenocarcinoma Treated with Total Neoadjuvant TherapyNathalie R A Beets, Floris S Verheij, Hannah Williams, et al.
Journal of Clinical Medicine|April 27, 2024
Oncologic Outcomes of Salvage Abdominoperineal Resection for Anal Squamous Cell Carcinoma Initially Managed with ChemoradiationRoni Rosen, Felipe F Quezada-Diaz, Mithat Gönen, et al.
Molecular Oncology|April 5, 2021
KRAS mutant rectal cancer cells interact with surrounding fibroblasts to deplete the extracellular matrixJin K Kim, Michael R Marco, Seo-Hyun Choi, et al.
Journal of Surgical Education|August 27, 2020
Does Intentional Support of Degree Programs in General Surgery Residency Affect Research Productivity or Pursuit of Academic Surgery? A Multi-Institutional StudyChelsea A Isom, Erika Kristen Bisgaard, Kendrick M Campbell, et al.
NPJ Precision Oncology|May 31, 2024
Mediator kinase inhibition impedes transcriptional plasticity and prevents resistance to ERK/MAPK-targeted therapy in KRAS-mutant cancersDaniel P Nussbaum, Colin A Martz, Andrew M Waters, et al.
Pharmacoepidemiology and Drug Safety|October 10, 2024
The FDA Sentinel Real World Evidence Data Enterprise (RWE-DE)Rishi J Desai, Keith Marsolo, Joshua Smith, et al.
JAMA Oncology|March 23, 2018
Adoption of Total Neoadjuvant Therapy for Locally Advanced Rectal CancerAndrea Cercek, Campbell S D Roxburgh, Paul Strombom, et al.
JCI Insight|August 18, 2017
MTG16 is a tumor suppressor in colitis-associated carcinomaElizabeth M McDonough, Caitlyn W Barrett, Bobak Parang, et al.
Pageof 32